Dissolvable oral products such as Philip Morris International’s Zyn Melts and Japan Tobacco International’s Perlz represent the industry's latest push into non-combustible alternatives. These mint and berry-flavored tablets contain smaller nicotine doses than conventional pouches, which usually offer between 3 and 17 milligrams. While market analysts see the format satisfying consumer demand for convenient stimulants, health authorities remain challenged by the need to balance harm reduction for adult smokers against youth initiation risks.
Key points
Public health researchers worry the candy-like tablets will attract teenagers and expand…: Public health researchers worry the candy-like tablets will attract teenagers and expand nicotine addiction in younger demographics.
Health experts note that long-term risks are undetermined and that many consumers use nov…: Health experts note that long-term risks are undetermined and that many consumers use novel products alongside combustible cigarettes.
Regulators like the Food and Drug Administration continue to face difficulties balancing…: Regulators like the Food and Drug Administration continue to face difficulties balancing adult cessation benefits against adolescent appeal.
Sources checked by our analysis pipeline: 1
This article was first reported by The Examination, a nonprofit newsroom that investigates global health threats.
The latest product from the tobacco industry is a flavorful nicotine tablet that melts in your mouth, allowing users to get a buzz as discreetly as popping a mint — and amping up concerns that products to replace cigarettes are too appealing to kids and teens.
In the United Kingdom and Switzerland, Philip Morris International recently introduced Zyn Melts, mint-flavored tablets that provide a nicotine hit as quickly as smoking a cigarette. Japan Tobacco International launched a similar product called Perlz in the U.K. in May.
And in the U.S., Nic Nac Naturals, a nascent nicotine company based in Spokane, Wash., has been selling flavored lozenges called Nic Nac since 2022; they’re now available in about 3,000 stores nationwide.
Users tuck these tablets next to their gums, similar to how they use nicotine pouches. Like pouches, the new products come in colorful packaging and flavors such as mint and berry. But with tablets, there’s no wet sachet to discard.
Scientists investigating a fatal complication in a neurological clinical trial have presented detailed findings to help restore confidence across the sector. Although the exact trigger for the fatality remains undetermined, teams are actively designing new experimental protocols to safely advance future candidates. Industry leaders believe this emerging evaluation framework will allow developers to test, predict, and counter the novel safety risk in subsequent studies.
Rising workplace violence over the past five years has prompted healthcare facilities to pair de-escalation training and security portals with aggressive warning notices. However, research reveals these deterrents fail to prevent violence while simultaneously eroding compassion, trust, and communication during vulnerable moments. Consequently, families and individuals facing medical crises risk being alienated when seeking care.
According to a report by STAT, the Trump administration is seeking to integrate religious initiatives into federal addiction care policy through strategies like the Great American Recovery Initiative. Backers argue these centers are unfairly excluded from public grants simply due to their religious identity. However, public health professionals warn that subsidizing facilities that restrict standard, evidence-based medications could undermine proven medical standards for patient recovery.